4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0002064832-26-000008
Chief Scientific Officer gave up 3,413 shares (to pay taxes)
- Chief Scientific Officer acquired 6,875 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Or Yat Sun · Chief Scientific Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-12 | Grant or award : show line 1 in the form | +1,650 | 373,042 | D | ||
| 2026-02-12 | Grant or award : show line 2 in the form | +5,225 | 378,267 | D | ||
| 2026-02-12 | Shares withheld for taxes : show line 3 in the form | −3,413 | $14.25 | $48,635 | 374,854 | D |
Loading xslF345X05/form4.xml…